A detailed history of Essex Investment Management CO LLC transactions in Insmed Inc stock. As of the latest transaction made, Essex Investment Management CO LLC holds 77,193 shares of INSM stock, worth $5.5 Million. This represents 1.05% of its overall portfolio holdings.

Number of Shares
77,193
Previous 103,184 25.19%
Holding current value
$5.5 Million
Previous $6.91 Million 18.49%
% of portfolio
1.05%
Previous 1.37%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$62.0 - $79.01 $1.61 Million - $2.05 Million
-25,991 Reduced 25.19%
77,193 $5.64 Million
Q2 2024

Aug 12, 2024

SELL
$22.0 - $69.71 $119,790 - $379,570
-5,445 Reduced 5.01%
103,184 $6.91 Million
Q1 2024

May 03, 2024

BUY
$25.72 - $29.94 $15,997 - $18,622
622 Added 0.58%
108,629 $2.95 Million
Q4 2023

Feb 07, 2024

SELL
$23.42 - $31.74 $946,449 - $1.28 Million
-40,412 Reduced 27.23%
108,007 $3.35 Million
Q3 2023

Nov 09, 2023

BUY
$19.86 - $26.93 $779,246 - $1.06 Million
39,237 Added 35.94%
148,419 $3.75 Million
Q2 2023

Aug 14, 2023

BUY
$16.44 - $21.1 $263,401 - $338,064
16,022 Added 17.2%
109,182 $2.3 Million
Q1 2023

May 04, 2023

BUY
$16.26 - $21.73 $291,200 - $389,162
17,909 Added 23.8%
93,160 $1.59 Million
Q4 2022

Feb 02, 2023

BUY
$16.98 - $23.15 $431,529 - $588,334
25,414 Added 50.99%
75,251 $1.5 Million
Q3 2022

Nov 14, 2022

BUY
$20.88 - $28.21 $1.04 Million - $1.41 Million
49,837 New
49,837 $1.07 Million
Q4 2018

Feb 06, 2019

SELL
$11.6 - $18.7 $259,492 - $418,319
-22,370 Closed
0 $0
Q3 2018

Oct 16, 2018

BUY
$18.95 - $28.08 $423,911 - $628,149
22,370 New
22,370 $452,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.65B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Essex Investment Management CO LLC Portfolio

Follow Essex Investment Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.